“[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways 23, no. 1 (June 22, 2022). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1527.